Advisor Net Financial, Inc Bio Path Holdings Inc Transaction History

Advisor Net Financial, Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$2.99 - $4.17 $119 - $166	-40 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$1.81 - $38.86 $1,375 - $29,533	-760 Reduced 95.0%	40 $1,000
Q4 2018 Feb 08, 2019	BUY	$3.2 - $12.8 $2,560 - $10,240	800 New	800 $0

Ticker BPTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,160,160
Market Cap $7.73M
Description
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.